Researchers at Tel Aviv University's Gray Faculty of Medical & Health Sciences conducted a series of experiments using advanced technologies, focusing on the tumor microenvironment in advanced stages of breast cancer. They ...
Jun 4, 2025
0
0
Virginia Tech researchers are developing more precise treatments for pediatric brain cancer using a new class of therapies that target cancer cells while sparing healthy tissue.
Jun 4, 2025
0
0
After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan Health since early 2024.
Jun 3, 2025
0
0
When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic complexity.
Jun 2, 2025
0
14
Radionuclide therapy with the radioactive element terbium could effectively combat lymphoma. This is demonstrated by promising results from experiments carried out at the Paul Scherrer Institute PSI in collaboration with ...
Jun 2, 2025
0
0
Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly ...
Jun 2, 2025
0
0
A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing brain cancer. Tumors became smaller after the experimental CAR T cell therapy in nearly two-thirds ...
Jun 1, 2025
0
65
A new targeted cancer drug, DB-1310, is showing early signs of effectiveness in patients with advanced solid tumors that have not responded to standard treatments, particularly those with EGFR-mutant non-small cell lung cancer ...
May 30, 2025
0
0
Researchers have uncovered that some childhood cancers have a substantially higher number of DNA changes than previously thought, changing the way we view children's tumors and possibly opening up new or repurposed treatment ...
May 29, 2025
0
52
Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.
May 29, 2025
0
0
